Fasciolosis is among the most economically important helminth infections in livestock, with global prevalence influenced by climatic conditions, presence of snail intermediate hosts (Lymnaea spp.), and grazing systems (Mas-Coma et al., 2009). Chronic infection leads to reduced feed efficiency, decreased milk yield, anemia, and condemned livers at slaughter.

Clostridial diseases, caused by spore-forming anaerobic bacteria of the genus Clostridium, often manifest as peracute or acute conditions with high mortality. Dormant clostridial spores can remain latent in tissues for long periods and become activated when anaerobic conditions develop. Liver fluke migration is a major trigger for such anaerobic microenvironments, particularly for Clostridium novyi type B.

Biology of Liver Flukes Relevant to Clostridial Disease

Immature liver flukes migrate through the hepatic parenchyma for 6–8 weeks before reaching the bile ducts. During this phase, they cause:

These pathological changes are essential in creating localized hypoxic environments suitable for clostridial spore germination (Dalton et al., 2017).

Clinical signs and symptoms

Acute FasciolosisChronic Fasciolosis
Sudden death (especially in sheep)
Severe anemia
Abdominal pain
Ascites
Hemorrhage in liver
Progressive weight loss
Reduced feed intake
Decreased milk production
Anemia
Bottle jaw
Poor growth and fertility problems

Post-mortem findings:

Clostridial Spores and Mechanism of Activation

Clostridium novyi type B spores are common in soil and can reach the liver hematogenously. They remain dormant until anaerobic conditions trigger germination. Immature flukes create foci of necrosis, oxygen depletion, and cell debris, providing an optimal environment for spore activation (Uzal et al., 2016).

Once activated:

This process is responsible for the peracute and often fatal course of Black Disease.

Zoonotic Importance

Fasciolosis is a zoonotic disease. Humans can get infected by consuming raw aquatic plants like watercress contaminated with metacercariae.

By:
Eliyas Rebuma (DVM)
Technical Marketing Manager
Ashish Life Science Ethiopia

Leave a comment